How Do Cardiovascular Risks Change Over Time in Breast Cancer Survivors?
In this study, researchers evaluated changes in CVD risk factors and 10-year CVD risk from before to after a breast cancer diagnosis, and compared it with women who remained free of such a diagnosis. (Source: CancerNetwork)
Source: CancerNetwork - October 23, 2018 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

Can Eating Organic Food Lower Your Cancer Risk?
In a study, those who ate more organic produce, dairy, meat and other products had 25 percent fewer cancer diagnoses over all, especially lymphoma and breast cancer. (Source: NYT Health)
Source: NYT Health - October 23, 2018 Category: Consumer Health News Authors: RONI CARYN RABIN Tags: Organic Foods and Products Hazardous and Toxic Substances Breast Cancer Diet and Nutrition Pesticides Source Type: news

Organic food lowers blood and breast cancer risk, study finds
The survey of nearly 70,000 French adults comes amid a flurry of interest in the cancer risks of pesticides, spurred by this summer's Monsanto trial, which found Roundup gave a man cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - October 23, 2018 Category: Consumer Health News Source Type: news

ASTRO: Prostate RT works better than expected in black men
SAN ANTONIO - Radiation therapy (RT) could be more effective in African-American...Read more on AuntMinnie.comRelated Reading: CT lung screening may benefit racial minorities most ACR, SBI: Some black women need earlier breast screening Gap narrows in black, white breast cancer death rates Racial disparities continue in lung cancer treatment USPSTF: Why do more black women die from breast cancer? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 23, 2018 Category: Radiology Source Type: news

Can whole-body MRI be used in oncologic staging?
Offering similar performance to PET/CT but without requiring radiation dose,...Read more on AuntMinnie.comRelated Reading: Gadolinium-enhanced MRI with PET best for prostate cancer Whole-body MRI gains momentum for oncology cases Metastasis or incidental finding? Cardiac MRI gives answers Hybrid modalities disappoint in bone metastases accuracy PET/MRI detects distant metastasis of breast cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 23, 2018 Category: Radiology Source Type: news

Medical News Today: Immunotherapy successful against deadly breast cancer
A new trial confirms that a combination of immunotherapy and chemotherapy boosts survival rates for people with triple-negative breast cancer. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 23, 2018 Category: Consumer Health News Tags: Breast Cancer Source Type: news

Houston Methodist scientists create device to deliver immunotherapy without side effects
(Houston Methodist) Houston Methodist scientists have developed a nanodevice to deliver immunotherapy without side effects to treat triple-negative breast cancer. Inserted straight into a tumor, this device makes it possible to deliver a one-time, sustained-release dose that would eliminate the need for patients to undergo several IV treatments over time. Alessandro Grattoni chairman of nanomedicine at the Houston Methodist Research Institute invented the device and is corresponding author on a study in the Journal of Controlled Release. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 23, 2018 Category: International Medicine & Public Health Source Type: news

Actin cytoskeleton remodeling protects tumor cells against immune attack
(Luxembourg Institute of Health) Cancer cells have evolved multiple escape strategies to circumvent the body's immune defenses such as the attack by Natural Killer (NK) cells which normally swiftly kill abnormal cells by releasing cytotoxic products. While studying breast cancer cell lines, Dr. Cl é ment Thomas' research team at the Luxembourg Institute of Health (LIH) uncovered a previously unknown mechanism that leaves tumor cells unharmed by NK cell-mediated cytotoxicity. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 23, 2018 Category: Cancer & Oncology Source Type: news

The hi-tech patch to check if breast op is healing
Researchers at Imperial College London have developed the Hamlyn bio-patch, which could be used for breast cancer patients within as little as two years. (Source: the Mail online | Health)
Source: the Mail online | Health - October 22, 2018 Category: Consumer Health News Source Type: news

While Pregnancy May Be Possible After Chemo, How Many Patients ’ Plans Change?
While becoming pregnant is generally possible for younger breast cancer patients, researchers believe many women change their minds after treatment. (Source: CancerNetwork)
Source: CancerNetwork - October 22, 2018 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

You Can Cut Your Cancer Risk By Eating Organic, New Study Says
(CNN) — You can protect yourself from cancer by eating organic, a new study suggests. Those who frequently eat organic foods lowered their overall risk of developing cancer, a study published Monday in JAMA Internal Medicine finds. Specifically, those who primarily eat organic foods were more likely to ward off non-Hodgkin lymphoma and postmenopausal breast cancer compared to those who rarely or never ate organic foods. Led by Julia Baudry, an epidemiologist at Institut National de la Sante et de la Recherche Medicale in France, a team of researchers looked at the diets of 68,946 French adults. More than three-quarte...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - October 22, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Cancer Local TV Organic Source Type: news

Love Organics? Your Odds for Some Cancers May Fall
Eating more organically grown foods was linked to a 34 percent reduced risk of postmenopausal breast cancer, a 76 percent decreased risk for all lymphomas and an 86 percent reduced risk for non-Hodgkin lymphoma, a recent study found. (Source: WebMD Health)
Source: WebMD Health - October 22, 2018 Category: Consumer Health News Source Type: news

Chemoimmunotherapy Ups Survival in Triple-Negative Breast Cancer
MONDAY, Oct. 22, 2018 -- For patients with metastatic triple-negative breast cancer, atezolizumab plus nanoparticle albumin-bound (nab)-paclitaxel prolongs progression-free survival compared with placebo plus nab-paclitaxel, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 22, 2018 Category: Pharmaceuticals Source Type: news

Drug Cocktail Slows Progress of Aggressive Breast Cancer
Checkpoint inhibition combined with chemotherapy gives patients with triple-negative metastatic breast cancer about two months more time without significant tumor growth, a study finds. (Source: The Scientist)
Source: The Scientist - October 22, 2018 Category: Science Tags: News & Opinion Source Type: news

ONJ With Bone-Modifying Agents in Breast Cancer Patients ONJ With Bone-Modifying Agents in Breast Cancer Patients
Osteonecrosis of the jaw was reported in metastatic breast cancer patients treated with bone-modifying agents; the incidence was higher with denosumab compared with bisphosphonates.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 22, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Immunotherapy drug shows promise for aggressive type of breast cancer
The trial, at hundreds of sites in 41 countries, followed 902 patients and studied the combination of immunotherapy and chemotherapy (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - October 22, 2018 Category: Consumer Health News Source Type: news

You can cut your cancer risk by eating organic, a new study says
You can protect yourself from cancer by eating organic, a new study suggests. Those who frequently eat organic foods lowered their overall risk of developing cancer, a study published Monday in JAMA Internal Medicine finds. Specifically, those who primarily eat organic foods were more likely to ward off non-Hodgkin lymphoma and postmenopausal breast cancer compared to those who rarely or never ate organic foods. (Source: CNN.com - Health)
Source: CNN.com - Health - October 22, 2018 Category: Consumer Health News Source Type: news

PI3K Inhibitor Doubles PFS in HR+/HER2- Breast Cancer
(MedPage Today) -- Benefit limited to patients with PIK3CA mutations (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - October 22, 2018 Category: Primary Care Source Type: news

Trials for advanced breast cancer
(Source: CNN.com - Health)
Source: CNN.com - Health - October 22, 2018 Category: Consumer Health News Source Type: news

Trial: Chemo, antibody drug combo treats aggressive breast cancer
A combination of chemotherapy and antibody medication extended the lives of people with triple-negative breast cancer by up to 10 months in a new trial. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 22, 2018 Category: Consumer Health News Source Type: news

New immunotherapy drug shows promise for aggressive type of breast cancer
The trial, at hundreds of sites in 41 countries, followed 902 patients and studied the combination of immunotherapy and chemotherapy (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - October 22, 2018 Category: Consumer Health News Source Type: news

Chemo and immunotherapy together may help triple-negative breast cancer patients
New research is bringing hope to women with a hard-to-treat type of breast cancer. A study published over the weekend in the New England Journal of Medicine found that combining chemotherapy with an immunotherapy medicine added up to 10 months of survival time for patients with triple-negative breast cancer. Dr. David Agus joins "CBS This Morning" with more on the research. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - October 22, 2018 Category: Consumer Health News Source Type: news

Palbociclib and hormonal therapy may extend survival in advanced breast cancer patients
The drug palbociclib when combined with hormonal therapy extends the survival of patients with advanced breast cancer, according to research published in theNew England Journal of Medicine.The Guardian (Source: Society for Endocrinology)
Source: Society for Endocrinology - October 22, 2018 Category: Endocrinology Source Type: news

Not So Fast With Immune Therapy For Breast Cancer
Does this medicine offer the best shot at improving survival or quality-of-life, among all drugs approved or available in clinical trials? (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 22, 2018 Category: Pharmaceuticals Authors: Elaine Schattner, Contributor Tags: OTCMKTS:RHHBY Source Type: news

Health Highlights: Oct. 22, 2018
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Immunotherapy-Chemo Combo Extends Lives of Women With Aggressive Breast Cancer Treatment with immunotherapy plus chemotherapy extended the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 22, 2018 Category: General Medicine Source Type: news

'Treatment may extend advanced breast cancer survival'
Combining a drug with hormone therapy may extend the lives of some women with advanced breast cancer. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - October 22, 2018 Category: Consumer Health News Source Type: news

Immunotherapy-Chemo Combo Extends Lives of Women With Aggressive Breast Cancer
Title: Immunotherapy-Chemo Combo Extends Lives of Women With Aggressive Breast CancerCategory: Health NewsCreated: 10/22/2018 12:00:00 AMLast Editorial Review: 10/22/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - October 22, 2018 Category: Cancer & Oncology Source Type: news

Zoledronic acid improves disease-free survival in premenopausal HR+ early breast cancer
(European Society for Medical Oncology) Adjuvant treatment with the bone sparing drug zoledronic acid plus hormonal therapy with the aromatase inhibitor letrozole significantly increases disease-free survival compared to tamoxifen in premenopausal women with hormone receptor positive (HR+) early breast cancer, according to results reported at ESMO 2018 Congress in Munich. It is the first study to assess this specific combination in premenopausal breast cancer and adds to previous observations with zoledronic acid and anastrozole in premenopausal women receiving ovarian suppression. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 22, 2018 Category: Cancer & Oncology Source Type: news

Epigenetic therapy worth pursuing in hormone receptor positive advanced breast cancer
(European Society for Medical Oncology) Epigenetic therapy with histone deacetylase (HDAC) inhibitors is worth pursuing in hormone receptor positive advanced breast cancer, suggests a phase III trial reported today at the ESMO 2018 Congress in Munich. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 22, 2018 Category: Cancer & Oncology Source Type: news

Targeting specific genomic mutation in breast cancer improves outcomes, first study shows
(European Society for Medical Oncology) Targeting a common mutation in patients with hormone receptor positive (HR+) HER2 negative (HER2-) advanced breast cancer with the alpha-specific phosphatidylinositol-3-kinase (PI3K) inhibitor alpelisib significantly improves progression-free survival, according to late-breaking results reported at ESMO 2018. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 22, 2018 Category: Cancer & Oncology Source Type: news

Love Organic Foods? Your Odds for Some Cancers May Fall
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - October 22, 2018 Category: Cancer & Oncology Source Type: news

ASTRO: Radiation therapy slashes breast cancer recurrence
Whole-breast radiation therapy can significantly lower the risk of recurrent...Read more on AuntMinnie.comRelated Reading: Can dedicated breast PET identify suspicious lesions? Women still need breast imaging after mastectomy Is radiation therapy warranted for DCIS postlumpectomy? Microbubbles improve breast cancer radiation therapy ASTRO: Short radiation course safe for breast cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 21, 2018 Category: Radiology Source Type: news

ASTRO: Weekly breast radiation therapy is safe
A larger, weekly dose of radiation therapy has side effects that are comparable...Read more on AuntMinnie.comRelated Reading: Can dedicated breast PET identify suspicious lesions? Women still need breast imaging after mastectomy Is radiation therapy warranted for DCIS postlumpectomy? Microbubbles improve breast cancer radiation therapy ASTRO: Short radiation course safe for breast cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 21, 2018 Category: Radiology Source Type: news

Immunotherapy Wins in Triple-Negative Breast Cancer
(MedPage Today) -- Atezolizumab-chemo combo extends PFS, OS in metastatic disease (Source: MedPage Today OB/GYN)
Source: MedPage Today OB/GYN - October 21, 2018 Category: OBGYN Source Type: news

Novel PI3K inhibitor for Breast Cancer: Success at Last? Novel PI3K inhibitor for Breast Cancer: Success at Last?
A novel and highly selective PI3K inhibitor for breast cancer may succeed where two other similar but unselective drugs failed because of toxicity.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 21, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Palbociclib in Breast Cancer: New Overall Survival Data Palbociclib in Breast Cancer: New Overall Survival Data
Final results from the PALOMA 3 study show that addition of palbociclib to fulvestrant improves overall survival by 7 months, but the result was not statistically significant. So now what?Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 21, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

It ’ s concerning that many women who qualify for a mammogram don ’ t go for regular screening, in part due to common myths like mammograms “ are painful ” or “ cause cancer. ” During this Breast Cancer Awareness month, I urge women to check the facts https://go.usa.gov/xPnyD   .pic.twitter.com/DGz5Xvquky
It’s concerning that many women who qualify for a mammogram don’t go for regular screening, in part due to common myths like mammograms “are painful” or “cause cancer.” During this Breast Cancer Awareness month, I urge women to check the facts https://go.usa.gov/xPnyD . pic.twitter.com/DGz5Xvquky (Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - October 21, 2018 Category: Medical Devices Authors: ( at SGottliebFDA) Source Type: news

The MQSA was intended to address mammography quality concerns and it ’ s been a huge success. Image quality has improved, radiation dose has declined and equipment violations have all but disappeared. Today the 5-year breast cancer survival rate is 95%-99%, up from 84% in 1995.
The MQSA was intended to address mammography quality concerns and it’s been a huge success. Image quality has improved, radiation dose has declined and equipment violations have all but disappeared. Today the 5-year breast cancer survival rate is 95%-99%, up from 84% in 1995. (Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - October 21, 2018 Category: Medical Devices Authors: ( at SGottliebFDA) Source Type: news

Also, while most of FDA ’ s women ’ s health initiatives are product specific, the #FDA plays an outsize role when it comes to mammography, which produces low-dose x-ray picture of the breast – an important tool to detect breast cancer in its early, most treatable stages.pic.twitter.com/aoYjsSEPrC
Also, while most of FDA’s women’s health initiatives are product specific, the #FDA plays an outsize role when it comes to mammography, which produces low-dose x-ray picture of the breast – an important tool to detect breast cancer in its early, most treatable stages. pic.twitter.com/aoYjsSEPrC (Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - October 21, 2018 Category: Medical Devices Authors: ( at SGottliebFDA) Source Type: news

Drug may hold key to cure for breast cancer
A BREAKTHROUGH breast cancer treatment has prolonged patients' lives in a trial that could even lead to a cure, scientists say. (Source: Daily Express - Health)
Source: Daily Express - Health - October 21, 2018 Category: Consumer Health News Source Type: news

New immunotherapy drug showing promise for aggressive type of breast cancer
The trial, at hundreds of sites in 41 countries, followed 902 patients and studied the combination of immunotherapy and chemotherapy (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - October 21, 2018 Category: Consumer Health News Source Type: news

Study says drug could help women with aggressive type of breast cancer
A new study shows a drug targeting the immune system could help women with an aggressive type of breast cancer. The results were announced at a conference in Europe and could change the way women are treated. Dr. Jon LaPook reports. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - October 20, 2018 Category: Consumer Health News Source Type: news

Immunotherapy scores a first win against some breast cancers
A newer immunotherapy drug for the first time has shown promise against breast cancer in a large study that combined it with chemotherapy to treat an aggressive form of the disease (Source: ABC News: Health)
Source: ABC News: Health - October 20, 2018 Category: Consumer Health News Tags: Health Source Type: news

Roche scores win in slowing aggressive type of breast cancer
An immunotherapy cocktail from Roche helped slow an aggressive type of breast cancer where new treatments have proven elusive, offering positive news for the Swiss drugmaker as it chases medicines produced by its rivals. (Source: Reuters: Health)
Source: Reuters: Health - October 20, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Immunotherapy-chemo combo extends life for women with aggressive form of breast cancer, study finds
A combination of chemotherapy and immunotherapy added months to the lives of women with triple-negative breast cancer, an aggressive type that attacks women under 50. (Source: CNN.com - Health)
Source: CNN.com - Health - October 20, 2018 Category: Consumer Health News Source Type: news

New Hope in Triple Negative Breast Cancer with Immunotherapy New Hope in Triple Negative Breast Cancer with Immunotherapy
For the first time, a survival benefit with immunotherapy has been shown in breast cancer with atezolizumab plus chemotherapy in triple negative patients.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 20, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Roche's Tecentriq boosts survival in triple-negative breast cancer
An immunotherapy cocktail from Roche helped slow a type of breast cancer where new treatments have proven elusive, data released on Saturday showed, offering positive news for the Swiss drugmaker as it chases medicines produced by its rivals. (Source: Reuters: Health)
Source: Reuters: Health - October 20, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Novartis drug cut death risk by 35 percent in gene mutation breast cancer
An experimental cancer drug that Novartis hopes will raise the profile of its oncology portfolio cut the risk of death or disease progression by more than a third in breast cancer patients with a hard-to-target gene mutation. (Source: Reuters: Health)
Source: Reuters: Health - October 20, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Immune-Based Treatment Helps Fight Aggressive Breast Cancer, Study Finds
Combining immunotherapy and chemotherapy can help women with an aggressive type of breast cancer and should become their new standard of care. (Source: NYT Health)
Source: NYT Health - October 20, 2018 Category: Consumer Health News Authors: DENISE GRADY Tags: Breast Cancer Clinical Trials Immune System Immunotherapy Nobel Prizes Chemotherapy Genentech Inc Roche Holding AG Tecentriq Source Type: news

A New Type of Treatment Shows Promise Against Aggressive Breast Cancer
This study is proof of principle that we should keep going,” Litton says. She is investigating whether there is a way for people who have already started chemotherapy to learn whether they will respond to the standard cycle of chemotherapy drugs, or should be switched to immunotherapy combinations for better results. Adams is also hopeful that other immunotherapy drugs may be developed that are more effective in activating the immune system against breast cancer cells specifically. “I expect these results will really invigorate the field and bring new research to help patients,” she says. (Source: TIME: Health)
Source: TIME: Health - October 20, 2018 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized breast cancer news healthytime Source Type: news